rs775464903

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5

The NM_000251.3(MSH2):​c.2320A>G​(p.Ile774Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 31)

Consequence

MSH2
NM_000251.3 missense

Scores

1
10
8

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:6U:1

Conservation

PhyloP100: 5.62
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 2-47478381-A-G is Pathogenic according to our data. Variant chr2-47478381-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 408475.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Uncertain_significance=1, Pathogenic=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MSH2NM_000251.3 linkc.2320A>G p.Ile774Val missense_variant Exon 14 of 16 ENST00000233146.7 NP_000242.1 P43246-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MSH2ENST00000233146.7 linkc.2320A>G p.Ile774Val missense_variant Exon 14 of 16 1 NM_000251.3 ENSP00000233146.2 P43246-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
May 06, 2019
Clinical Genetics and Genomics, Karolinska University Hospital
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 27, 2022
Clinical Genetics Laboratory, Skane University Hospital Lund
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Lynch syndrome 1 Pathogenic:1
May 19, 2023
Baylor Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Gastric cancer Pathogenic:1
Jul 01, 2021
Laboratory for Genotyping Development, RIKEN
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
Dec 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 774 of the MSH2 protein (p.Ile774Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of Lynch syndrome (PMID: 28765196; external communication, internal data). Invitae Evidence Modeling of clinical and family history, age, sex, and reported ancestry of multiple individuals with this MSH2 variant has been performed. This variant is expected to be pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model that incorporates the clinical features of 1,370,736 individuals referred to our laboratory for MSH2 testing. ClinVar contains an entry for this variant (Variation ID: 408475). Invitae Evidence Modeling incorporating data from in vitro experimental studies (PMID: 33357406) indicates that this missense variant is not expected to disrupt MSH2 function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect MSH2 function (PMID: 33357406). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -

Hereditary cancer-predisposing syndrome Pathogenic:1
Sep 16, 2024
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.I774V pathogenic mutation (also known as c.2320A>G), located in coding exon 14 of the MSH2 gene, results from an A to G substitution at nucleotide position 2320. The isoleucine at codon 774 is replaced by valine, an amino acid with highly similar properties. This alteration has been reported in an individual who met Bethesda, but not Amsterdam criteria, and had osteosarcoma as well as early-onset, mismatch repair deficient rectal cancer displaying loss of MSH2 and MSH6 on immunohistochemistry (IHC) (de Rosa N et al. J. Clin. Oncol., 2016 Sep;34:3039-46; Borras E et al. Cancer Prev. Res. (Phila.), 2017 Oct;10:580-587). This alteration was also identified in several individuals whose family history met Amsterdam I/II criteria for Lynch syndrome and/or colorectal tumor showed loss of MSH2 protein expression by IHC and/or high microsatellite instability (MSI-H) (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site. RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, as a missense substitution this is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. -

Lynch syndrome Uncertain:1
Mar 28, 2023
All of Us Research Program, National Institutes of Health
Significance: Uncertain significance
Review Status: flagged submission
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Pathogenic
0.16
D
BayesDel_noAF
Uncertain
0.0
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T;.;.;.
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.82
T;T;D;D
M_CAP
Benign
0.052
D
MetaRNN
Uncertain
0.65
D;D;D;D
MetaSVM
Uncertain
-0.082
T
MutationAssessor
Benign
1.4
L;.;.;.
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.81
N;N;.;N
REVEL
Uncertain
0.58
Sift
Benign
0.047
D;D;.;D
Sift4G
Benign
0.087
T;T;.;T
Polyphen
0.53
P;.;.;P
Vest4
0.58
MutPred
0.64
Gain of methylation at K773 (P = 0.0531);.;Gain of methylation at K773 (P = 0.0531);Gain of methylation at K773 (P = 0.0531);
MVP
0.87
MPC
0.013
ClinPred
0.79
D
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.33
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.79
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.79
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs775464903; hg19: chr2-47705520; API